Abstract:Abstract Herein we report the identification and characterisation of two linear antimicrobial peptides (AMPs), HG2 and HG4, with activity against a wide range of multidrug resistant (MDR) bacteria, especially methicillin resistant Staphylococcus aureus (MRSA) strains, a highly problematic group of Gram-positive bacteria in the hospital and community environment. To identify the novel AMPs presented here, we employed the classifier model design, a feature extraction method using molecular descriptors for amino acids for the analysis, visualization, and interpretation of AMP activities from a rumen metagenomic dataset. This allowed for the in silico discrimination of active and inactive peptides in order to define a small number of promising novel lead AMP test candidates for chemical synthesis and experimental evaluation. In vitro data suggest that the chosen AMPs are fast acting, show strong biofilm inhibition and dispersal activity and are efficacious in an in vivo model of MRSA USA300 infection, whilst showing little toxicity to human erythrocytes and human primary cell lines ex vivo . Observations from biophysical AMP-lipid-interactions and electron microscopy suggest that the newly identified peptides interact with the cell membrane and may be involved in the inhibition of other cellular processes. Amphiphilic conformations associated with membrane disruption are also observed in 3D molecular modelling of the peptides. HG2 and HG4 both preferentially bind to MRSA total lipids rather than with human cell lipids indicating that HG4 may form superior templates for safer therapeutic candidates for MDR bacterial infections. Author Summary We are losing our ability to treat multidrug resistant (MDR) bacteria, otherwise known as superbugs. This poses a serious global threat to human health as bacteria are increasingly acquiring resistance to antibiotics. There is therefore urgent need to intensify our efforts to develop new safer alternative drug candidates. We emphasise the usefulness of complementing wet-lab and in silico techniques for the rapid identification of new drug candidates from environmental samples, especially antimicrobial peptides (AMPs). HG2 and HG4, the AMPs identified in our study show promise as effective therapies for the treatment of methicillin resistant Staphylococcus aureus infections both in vitro and in vivo whilst having little cytotoxicity against human primary cells, a step forward in the fight against MDR infections.

Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects

Structure–Activity Predictions From Computational Mining of Protein Databases to Assist Modular Design of Antimicrobial Peptides

Mining Amphibian and Insect Transcriptomes for Antimicrobial Peptide Sequences with rAMPage

Antimicrobial peptides designed by computational analysis of proteomes

A novel bioinformatic method for the identification of antimicrobial peptides in metagenomes

AMPlify: attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens

High Throughput Meta-analysis of Antimicrobial Peptides for Characterizing Class Specific Therapeutic Candidates: An Approach

Bioprospecting of Culturable Marine Biofilm Bacteria for Novel Antimicrobial Peptides

Mining the UniProtKB/Swiss-Prot database for antimicrobial peptides

Engineering Antimicrobial Peptides with Improved Antimicrobial and Hemolytic Activities

Computational resources and tools for antimicrobial peptides

Unveiling Encrypted Antimicrobial Peptides from Cephalopods' Salivary Glands: A Proteolysis-Driven Virtual Approach

In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method

In silico identification of novel peptides with antibacterial activity against multidrug resistant Staphylococcus aureus

Screening and computational characterization of novel antimicrobial cathelicidins from amphibian transcriptomic data

Designing antimicrobial peptides using deep learning and molecular dynamic simulations

An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining

Antimicrobial Peptides as Broad-Spectrum Therapeutics: Computational Analysis to Identify Universal Physical-Chemical Features Responsible for Multitarget Activity

Discovery of AMPs from random peptides via deep learning-based model and biological activity validation

Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides

Little Antimicrobial Peptides with Big Therapeutic Roles